CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a non-invasive diagnostic tool for Non-Alcoholic Fatty Liver Disease (NAFLD) using proprietary imaging biomarkers. The goal is to provide a cost-effective alternative to liver biopsy for early detection and management of the disease.
The overall objective of the project as a whole is to provide to the global clinical community a non-invasive diagnostic tool for the management of the NAFLD (Non Alcoholic Fatty Liver Disease) through an ON-LINE SERVICE OF DIAGNOSTIC TEST
as alternative to Liver Biopsy.This project innovative approach is based on two verified proprietary imaging biomarkers linked to the evidence of NASH existence (Non Alcoholic Steatohepatitis) and fibrosis staging in patients with NAFLD, as
well as a robust an…
Talemnology S.L.
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
